(NASDAQ: DRIO) Dariohealth's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of 16.08%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 42.93%.
Dariohealth's earnings in 2025 is -$59,497,000.On average, 6 Wall Street analysts forecast DRIO's earnings for 2025 to be -$61,721,176, with the lowest DRIO earnings forecast at -$59,300,738, and the highest DRIO earnings forecast at -$63,536,505. On average, 6 Wall Street analysts forecast DRIO's earnings for 2026 to be -$22,739,381, with the lowest DRIO earnings forecast at -$28,981,564, and the highest DRIO earnings forecast at -$10,032,080.
In 2027, DRIO is forecast to generate -$24,131,588 in earnings, with the lowest earnings forecast at -$23,185,251 and the highest earnings forecast at -$24,841,340.